Breast Cancer
Breast tumors counteract the antiangiogenic effect of stromal protein
Published in Cancer Weekly, October 4th, 2005
According to a study from France, "the antiangiogenic extracellular matrix protein thrombospondin-1 (TSP-1) inhibits tumor growth and metastasis in animals. However, the clinical relevance of such findings are equivocal as increased stromal TSP-1 expression has been associated with either good or poor prognosis."
"In an effort to obtain a more integrated understanding of the role of TSP-1 in breast cancer, we first used a breast tumorigenesis model in which tumor-associated stromal fibroblasts were engineered to produce high levels of TSP-1. We demonstrate here that stromal TSP-1...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-10-04)
More Articles from Cancer Weekly
- Brain Cancer
TrkA induced apoptosis of neuroblastoma cells via p53-dependent mechanism - Breast Cancer
Catechol-O-methyltransferase polymorphism studied as predictor for breast cancer - Islet Transplantation
Islet hormones and N-nitrosomorpholine have carcinogenic effects - Lymphoma
Ciprofloxacin affected cyclophosphamide pharmacokinetics in NHL patients - Ovarian Cancer
Weekly topotecan administered to heavily pretreated patients - Acute Myeloid Leukemia
PEP005 has potent antileukemic activity mediated via delta isoform of PKC - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
